Alnylam Pharmaceuticals (ALNY) Shareholder's Equity Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.35% |
| Dec 31, 2025 | 1,076.33% |
| Sep 30, 2025 | 622.92% |
| Jun 30, 2025 | 8,270.56% |
| Mar 31, 2025 | 294.34% |
| Dec 31, 2024 | 130.41% |
| Sep 30, 2024 | 119.51% |
| Jun 30, 2024 | 99.25% |
| Mar 31, 2024 | 15.42% |
| Dec 31, 2023 | -39.45% |
| Sep 30, 2023 | -145.23% |
| Jun 30, 2023 | -331.84% |
| Mar 31, 2023 | -164.62% |
| Dec 31, 2022 | -126.90% |
| Sep 30, 2022 | -108.95% |
| Jun 30, 2022 | -79.37% |
| Mar 31, 2022 | -56.69% |
| Dec 31, 2021 | -42.12% |
| Sep 30, 2021 | -37.79% |
| Jun 30, 2021 | -39.03% |
| Mar 31, 2021 | -31.38% |
| Dec 31, 2020 | -29.36% |
| Sep 30, 2020 | -24.40% |
| Jun 30, 2020 | -20.34% |
| Mar 31, 2020 | -12.75% |
| Dec 31, 2019 | 10.50% |
| Sep 30, 2019 | 8.73% |
| Jun 30, 2019 | 8.42% |
| Mar 31, 2019 | -11.84% |
| Dec 31, 2018 | -26.29% |
| Sep 30, 2018 | 39.60% |
| Jun 30, 2018 | 44.33% |
| Mar 31, 2018 | 111.19% |
| Dec 31, 2017 | 91.96% |
| Sep 30, 2017 | 4.32% |
| Jun 30, 2017 | 2.23% |
| Mar 31, 2017 | -30.12% |
| Dec 31, 2016 | -27.24% |
| Sep 30, 2016 | -23.20% |
| Jun 30, 2016 | -22.02% |
| Mar 31, 2016 | -20.55% |
| Dec 31, 2015 | 35.08% |
| Sep 30, 2015 | 46.12% |
| Jun 30, 2015 | 49.49% |
| Mar 31, 2015 | 56.71% |
| Dec 31, 2014 | 246.32% |
| Sep 30, 2014 | 203.94% |
| Jun 30, 2014 | 205.76% |
| Mar 31, 2014 | 206.52% |
| Dec 31, 2013 | 101.67% |
| Sep 30, 2013 | 67.97% |
| Jun 30, 2013 | 63.67% |
| Mar 31, 2013 | 57.85% |
| Dec 31, 2012 | 13.61% |
| Sep 30, 2012 | 38.54% |
| Jun 30, 2012 | 37.89% |
| Mar 31, 2012 | 35.59% |
| Dec 31, 2011 | -25.43% |
| Sep 30, 2011 | -20.40% |
| Jun 30, 2011 | -17.48% |
| Dec 31, 2010 | -11.09% |